4-aminopyridine Treatment for Nerve Injury From Radical Retro-Pubic Prostatectomy
Status:
Withdrawn
Trial end date:
2018-10-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if the study drug 4-aminopyridine (4-AP) can help speed
up the recovery of peripheral nerve injury after prostatectomy. 4-AP is a potassium channel
blocker used to improve walking in multiple sclerosis patients. Investigators will measure
the effect that 4-AP may have on the recovery of sexual function and urinary incontinence
after prostatectomy.